MedPath

Fast Brain MRI in Children With Suspected Brain Tumor

Recruiting
Conditions
Diagnosis
Brain Neoplasms, Childhood
Image
Magnetic Resonance Imaging
Brain Neoplasms
Neuroimaging
Brain Tumor
Pediatric
Interventions
Diagnostic Test: Fast MRI (Neuromix)
Registration Number
NCT05776602
Lead Sponsor
Karolinska University Hospital
Brief Summary

This study aims to assess the diagnostic performance of a new fast MRI sequence named Neuromix compared to routine clinical MRI for brain tumor in pediatric patients

Detailed Description

The study aims to assess the diagnostic performance of fast MR sequence for the radiological evaluation of brain tumor in comparison to routine clinical MRI (or reference standard) in a pediatric population.

The primary outcome is the depiction and characterization of normal brain, brain tumor pathology and incidental findings.

Sensitivity, specificity, AUC and intra-/ interreader agreement for the diagnostic performance of Neuromix compared to cMRI will be obtained. Correlation of results between methods will be calculated.

Secondary outcomes will also include the assessment of diagnostic image quality and image artifacts.

The study population will consist of subjects aged 0-18 with a suspected or diagnosed brain tumor referred for routine MRI examination of the brain.

Study subjects will be investigated during the same day at 3T MR with Neuromix sequence in addition to the routine MRI examination.

Volume measurements will be compared.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age 0-18 years.
  • Pediatric subjects with diagnosed or suspected brain tumor
  • Referral routine MRI study.
Exclusion Criteria
  • MRI planned without sedation
  • Aborted MR exam
  • Unstable patient

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pediatric patients with suspected or confirmed brain tumorFast MRI (Neuromix)New method och standard MRI in clinical care
Primary Outcome Measures
NameTimeMethod
Diagnostic performanceThrough study completion, an average of 1 year

AUC, area under the curve for the comparison of the new method against the reference standard

Secondary Outcome Measures
NameTimeMethod
Imaging qualitythrough study completion, an average of 1 year

Image quality on both methods

Agreementthrough study completion, an average of 1 year

Agreement between readers and methods

Sensitivitythrough study completion, an average of 1 year

Sensitivity of the new method against the reference standard

Imaging artifactsthrough study completion, an average of 1 year

Image artifacts on both methods

Correlationthrough study completion, an average of 1 year

Correlation between readers and methods

Specificitythrough study completion, an average of 1 year

Specificity of the new method against the reference standard

Trial Locations

Locations (1)

Karolinksa Universitetssjukhuset

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath